RUA Life Sciences
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's only operating segment; exploiting the value of its IP and know-how. Geographically, it derives most of the revenue from the USA and has a presence in Europe and the Rest of the world. It has developed biostable, implantable polymers, including technology such as Elast-Eon, Elast-Eon Carbonate Silicone, and Elast-Eon Reaction Injection Molding (RIM) technology. Also, the company has developed a range of large bore vascular grafts. The company earns its revenues in the form of royalties and license fees.